|1|Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis. (26943143)
Park M.G.... Lee J.W.
|2|Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. (25634174)
Chen S.P.... Jiang N.
|3|Expression of hepatocyte growth factor in prostate cancer may indicate a biochemical recurrence after radical prostatectomy. (25550581)
Nishida S.... Masumori N.
|4|I^-Arrestin2 Contributes to Cell Viability and Proliferation via the Down-Regulation of FOXO1 in Castration-Resistant Prostate Cancer. (25752515)
Duan X.... Zeng G.
|5|TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation. (25263440)
Mounir Z.... Pagliarini R.
|6|Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome. (26008593)
Zhu Y.... Sun Y.
|7|MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer. (26059417)
Nishikawa R.... Seki N.
|8|Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells. (24727455)
Cai L.... Wang Z.
|9|Measurement of serum PSA as a predictor of symptoms scored on the IPSS for patients with benign prostatic hyperplasia. (24548953)
Lim C.F.... Buchan N.C.
|10|Association of increased levels of TGF-I^1 and p14ARF in prostate carcinoma cell lines overexpressing Egr-1. (25224321)
Parra E.... Ferreira J.
|11|Re: Effect of Soy Protein Isolate Supplementation on Biochemical Recurrence ofA Prostate Cancer after Radical Prostatectomy: A Randomized Trial. (24331479)
|12|Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells. (24981110)
Jeet V.... Nelson C.
|13|Lumican expression, localization and antitumor activity in prostate cancer. (23399832)
Coulson-Thomas V.J.... Nader H.B.
|14|Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. (23676682)
Pickard M.R.... Williams G.T.
|15|Pre-prostatic tissue removed in robotic assisted lymph node dissection for prostate cancer contains lymph nodes. (24311906)
Blarer J.... Horstmann M.
|16|No evidence of FGFR3 mutations in prostate cancer. (20957671)
Zuiverloon T.C.... Zwarthoff E.C.
|17|PPARI^ disease gene network and identification of therapeutic targets for prostate cancer. (21780947)
Venkatachalam G.... Sakharkar M.K.
|18|Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. (19820934)
Seliger B.... Hartmann A.
|19|CYP17 polymorphisms and prostate cancer outcomes. (20503394)
Wright J.L.... Stanford J.L.
|20|Other biomarkers for detecting prostate cancer. (19930175)
Nogueira L.... Eastham J.A.
|21|Investigative clinical study on prostate cancer part III: exploring total PSA and free testosterone distributions and linear correlations in groups and subgroups of operated prostate cancer patients according to the total PSA/FT ratio. (20948186)
Porcaro A.B.... Comunale L.
|22|Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. (18762814)
Jhavar S.... Parker C.
|23|Y chromosome haplotypes and prostate cancer in Sweden. (18927315)
LindstrAPm S.... Wiklund F.
|24|A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. (18703514)
Li H.... Srivastava S.
|25|Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. (17443494)
Endsley M.P.... Nithipatikom K.
|26|Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer. (16698360)
Srinivas S.... Feldman D.
|27|The hidden condition: status, challenges, and opportunities in the management of enlarged prostate for managed care. (16551205)
Naslund M.J.... Eaddy M.T.
|28|Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. (17079215)
Mambula S.S.... Calderwood S.K.
|29|Characterization of frequently deleted 6q locus in prostate cancer. (17132090)
Sun M.... Srivastava S.
|30|Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. (15280008)
Montano X.... Djamgoz M.B.
|31|Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease. (14716676)
Martiniello-Wilks R.... Russell P.J.
|32|Vitamin D receptor gene Bsm I polymorphism and the susceptibility to prostate cancer in northern Chinese Han population]. (14574802)
Liu J.H.... Na Y.Q.
|33|A comparative study of prostate specific antigen (PSA), C-terminal propeptide of blood type I procollagen (PICP) and urine type I collagen-crosslinked N telopeptide (NTx) levels using bone scintigraphy in prostate cancer patients. (12932112)
Fukumitsu N.... Nakada J.
|34|Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma. (12949839)
JimAcnez N.... Montuenga L.M.
|35|Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. (14695191)
Kazansky A.V.... Greenberg N.M.
|36|A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer. (11996476)
Sweeney C.J.... Einhorn L.H.
|37|Inhibition of nuclear factor kappaB induces apoptosis following treatment with tumor necrosis factor alpha and an antioxidant in human prostate cancer cells. (12269771)
Gunawardena K.... Meikle A.W.
|38|Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. (11929948)
Jing C.... Ke Y.
|39|The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. (12239635)
Haslmayer P.... Obrist P.
|40|A novel human cancer culture model for the study of prostate cancer. (11753687)
Yasunaga Y.... Rhim J.S.
|41|Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review. (11141722)
D'Aprile M.... Tonini G.
|42|BRCA1 and BRCA2 have a limited role in familial prostate cancer. (10728701)
Sinclair C.S.... Couch F.J.
|43|Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology. (10699620)
Schatzl G.... Madersbacher S.
|44|Selective expression of inducible nitric oxide synthase in human prostate carcinoma. (9587122)
Klotz T.... Addicks K.
|45|NGF-beta, NE-cells and prostatic cancer cell lines. A study of neuroendocrine expression in the human prostatic cancer cell lines DU-145, PC-3, LNCaP, and TSU-pr1 following stimulation of the nerve growth factor-beta. (9561567)
Angelsen A.... Waldum H.L.
|46|Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein. (9275063)
Shan J.D.... Vihko P.
|47|Sorting of heparan sulfate proteoglycan into matrix compartments of prostate adenocarcinoma cells. (7830405)
Kosir M.A.... Quinn C.C.
|49|Variability of values of prostate-specific antigen determined with 6 methods]. (7514278)
Bangma C.H.... SchrAPder F.H.
|50|A case of spino-cerebellar degeneration associated with carcinoma of the prostate. (6021237)